Skip to main content
OpenTrials
Completed

NCT Number: NCT04369261

Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hanyang University GURI Hospital

Guri-si, Gyeonggi-do, 11923, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult male or female patient of over 19 years of age
  • A patient diagnosed with knee osteoarthritis
  • A patient who has been informed of the purpose, method of the study and signed the written informed consent form.

Exclusion criteria

  • A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj.
  • A patient with infection at the joint
  • A patient with skin infection or skin disease at the injection area
  • A patient diagnosed with osteoarthritis with the Kellgren & Lawrence Grade IV in X-ray within 12 months before enrollment of this study.

Treatment and study plan

Synovian®

Drug

Synovian® Inj.

Primary outcomes

  1. safety endpoints

    Time frame: Week 2

    injection site reactions

Sponsors and collaborators

Lead sponsor

LG Chem

Industry

Registry information

Official study title

A Multicenter, Prospective Observational Study to Evaluate the Injection Site Reactions of Synovian® Inj. in Patients With Osteoarthritis in the Knee

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Apr 30, 2020
Registry last updated
Apr 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.